8-K: Nuwellis, Inc. Restructures Preferred Stock, CEO Exchanges Shares Ahead of Potential Public Offering

Nuwellis, Inc. has filed a Certificate of Designation for new Series F-1 Convertible Preferred Stock and entered into an exchange agreement with CEO John L. Erb, converting his existing Series F shares into the new class, which includes a 19.99% beneficial ownership limitation, in anticipation of a future public offering.

Summary

• Nuwellis, Inc. (NUWE) filed a Certificate of Designation for 100 shares of Series F-1 Convertible Preferred Stock on June 6, 2025, authorizing their issuance.
• The Series F-1 Stock has a Stated Value of $1,000 per share and a conversion price of $4.50 per share of common stock.
• A key term of the Series F-1 Stock is a beneficial ownership limitation, preventing conversion if the holder (and affiliates) would beneficially own more than 19.99% of the outstanding common stock.
• On June 9, 2025, the Company entered into a Securities Exchange Agreement with its CEO and director, John L. Erb, to exchange his 100 shares of existing Series F Convertible Preferred Stock for 100 shares of the newly designated Series F-1 Stock.
• Following this exchange, Mr. Erb will own 100% of the Series F-1 Stock.
• Mr. Erb has committed to convert all (or as much as allowed by the beneficial ownership limitation) of his Series F-1 Preferred Stock on or before the date the Company executes an underwriting agreement for a public offering on Form S-1 (333-287663).
• Mr. Erb also agreed to vote his shares in favor of any resolution required by Nasdaq rules to approve the issuance and exercise of warrants related to the upcoming Form S-1 public offering.

Sentiment

Score: 6

Explanation: The filing indicates proactive capital structure management and preparation for a significant capital raise (public offering), which is generally positive for a company seeking growth. However, it's a procedural filing, not a performance update, so the sentiment is neutral to slightly positive, reflecting progress towards financing goals.

Positives

• The exchange simplifies the capital structure by converting existing preferred shares into a new series with specific, updated terms.
• The CEO's agreement to convert shares and vote in favor of the upcoming public offering indicates strong management alignment with future capital raising efforts.
• The 19.99% beneficial ownership limitation is a standard provision that can help avoid triggering certain shareholder approval requirements or change of control provisions.

Negatives

• The 19.99% beneficial ownership limitation restricts the immediate full conversion of the Series F-1 Preferred Stock by the holder, potentially delaying full conversion into common stock.
• The terms of the Series F-1 Preferred Stock, including potential liquidated damages for failure to deliver conversion shares, could impose financial penalties on the company if it fails to meet its obligations.

Risks

• Dilution Risk: Future conversion of the Series F-1 Preferred Stock into common stock will increase the number of outstanding common shares, potentially diluting existing common shareholders.
• Market Conditions Risk: The ability to conduct the anticipated public offering on Form S-1 (333-287663) is subject to market conditions and regulatory approvals.
• Operational Risk: The company's ability to meet its obligations, such as timely delivery of conversion shares, is crucial to avoid liquidated damages.
• Equity Conditions Risk: The company's ability to exercise optional redemption is contingent on meeting several "Equity Conditions," which include having an effective registration statement, sufficient authorized shares, and no pending Fundamental Transactions.

Future Outlook

The company is preparing for a public offering on Form S-1 (333-287663), with the CEO's share exchange and voting commitment aligning with this future capital raising initiative.

Management Comments

• "John L. Erb, the Company's Chief Executive Officer and member of the board of directors, entered into a Securities Exchange Agreement to exchange 100 shares of outstanding Existing Series F Stock for 100 shares of the newly designated Series F-1 Stock."
• "Mr. Erb will own 100% of the Series F-1 Stock following the Exchange."
• "Mr. Erb agrees and covenants with the Company to convert all (or, such amount as available under the Beneficial Ownership Limitation) of the Series F-1 Preferred Stock on or before 4:00 p.m. ET on (i) the date that the Company executes an underwriting agreement for a public offering on Form S-1 (333-287663) if such underwriting agreement is signed before 9:30 AM or (ii) the business day immediately following the date the Company executes an underwriting agreement for a public offering on Form S-1 (333-287663) if such underwriting agreement is signed after 4:00 PM."
• "Mr. Erb also agrees and covenants to vote all shares of the Company's voting stock over which the Holder has voting control in favor of any resolution presented to the shareholders of the Company to approve the issuance and exercise of certain warrants of the Company being issued pursuant to its underwritten public offering on Form S-1 (333-287663) as may be required by the applicable rules and regulations of the Nasdaq Capital Market."

Industry Context

This corporate action is specific to Nuwellis's capital structure management and preparation for a potential public offering. It does not directly reflect broader industry trends but is a common step for companies seeking to optimize their financing ahead of market activities.

Comparison to Industry Standards

• The 19.99% beneficial ownership limitation is a common provision in convertible securities, often used to prevent triggering certain change-of-control provisions or shareholder approval requirements (e.g., Nasdaq Rule 5635(d)) that apply when a single investor's ownership exceeds 20%.
• The conversion price of $4.50 and stated value of $1,000 per share for preferred stock are specific to Nuwellis's valuation and capital needs, and their competitiveness would depend on a detailed comparison with recent preferred stock issuances by similar-stage medical device companies or those with comparable market capitalizations.
• The agreement for the CEO to convert shares and vote in favor of a future public offering is a strong signal of management's commitment to the company's financing strategy, a practice often seen in companies preparing for significant capital market events.

Corporate Governance

Related Party Transactions

• Nuwellis, Inc. entered into a Securities Exchange Agreement with John L. Erb, the Company's Chief Executive Officer and a member of the board of directors, to exchange 100 shares of his existing Series F Convertible Preferred Stock for 100 shares of the newly designated Series F-1 Convertible Preferred Stock.

Stakeholder Impact

• Shareholders: Potential dilution from future conversion of Series F-1 Preferred Stock and the upcoming public offering. The CEO's commitment to the public offering may be viewed positively.
• Management: The CEO's holdings are now under the new Series F-1 terms, aligning his interests with the company's financing strategy.

Next Steps

• The Company is expected to proceed with a public offering on Form S-1 (333-287663).
• John L. Erb is expected to convert his Series F-1 Preferred Stock upon the execution of an underwriting agreement for the public offering.
• Shareholders will be asked to vote on the issuance and exercise of certain warrants related to the public offering, as required by Nasdaq rules.

Key Dates

Keywords

Nuwellis, NUWE, Preferred Stock, Convertible Preferred Stock, Series F-1, Series F, Securities Exchange Agreement, John L. Erb, CEO, Capital Structure, SEC Filing, 8-K, Public Offering, Form S-1, Beneficial Ownership Limitation, Corporate Governance, Equity Securities